206 related articles for article (PubMed ID: 28571494)
1. Cardiovascular pleiotropic effects of statins and new onset diabetes: is there a common link: do we need to evaluate the role of KATP channels?
Sehra D; Sehra S; Sehra ST
Expert Opin Drug Saf; 2017 Jul; 16(7):823-831. PubMed ID: 28571494
[TBL] [Abstract][Full Text] [Related]
2. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin Treatment Affects Both Basal and Glucose-Induced Insulin Secretion in INS-1 832/13 Cells.
Salunkhe VA; Elvstam O; Eliasson L; Wendt A
PLoS One; 2016; 11(3):e0151592. PubMed ID: 26986474
[TBL] [Abstract][Full Text] [Related]
4. The Pleiotropic Effects of Statins in Endocrine Disorders.
De La Cruz JA; Mihos CG; Horvath SA; Santana O
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):787-793. PubMed ID: 30924424
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic vascular protective effects of statins in perioperative medicine.
Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of statins.
Liao JK; Laufs U
Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
[TBL] [Abstract][Full Text] [Related]
9. Statin treatment and new-onset diabetes: a review of proposed mechanisms.
Brault M; Ray J; Gomez YH; Mantzoros CS; Daskalopoulou SS
Metabolism; 2014 Jun; 63(6):735-45. PubMed ID: 24641882
[TBL] [Abstract][Full Text] [Related]
10. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
Lavie G; Cohen S
Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
12. [Pathophysiological aspects of the diabetogenic effect of statins].
Pilemann-Lyberg S; Solis AB; Gæde P
Ugeskr Laeger; 2014 Feb; 176(3):223-7. PubMed ID: 24629748
[TBL] [Abstract][Full Text] [Related]
13. Beneficial cardiovascular pleiotropic effects of statins.
Davignon J
Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
[TBL] [Abstract][Full Text] [Related]
14. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
Bruckert E; Ferrières J
Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
[TBL] [Abstract][Full Text] [Related]
15. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
[TBL] [Abstract][Full Text] [Related]
16. Statins and their increased risk of inducing diabetes.
Agouridis AP; Kostapanos MS; Elisaf MS
Expert Opin Drug Saf; 2015; 14(12):1835-44. PubMed ID: 26437128
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
18. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
[TBL] [Abstract][Full Text] [Related]
19. Statins are diabetogenic--myth or reality?
Sattar N; Taskinen MR
Atheroscler Suppl; 2012 Aug; 13(1):1-10. PubMed ID: 22818818
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
